InBios – News and Events

June 8, 2020

APHL, June 8-11, 2020, Portland, OR, Booth 502

Nov. 20, 2019

ASTMH, Nov. 20-24, 2019, National Harbor, MD

August 4, 2019

AACC, August 4-8, 2019, Anaheim, CA, Booth 4309

June 12, 2019

Seattle’s InBios: First to Receive FDA Authorization for Zika Test

June 3, 2019

APHL, June 3-6, 2019, St. Louis, MO, Booth 334-336

May 29, 2019

First Diagnostic Test for Zika Gets FDA’s OK to Market

May 28, 2019

InBios Receives FDA Market Authorization for its ZIKV Detect 2.0 IgM Capture ELISA for a Presumptive Diagnosis of Zika Virus Infection

May 23, 2019

FDA Grants Marketing Authorization for First Diagnostic Test for Detecting Zika IgM Antibodies to InBios

January 29, 2019

ASM Biothreats, January 29-31, 2019, Arlington, VA, Booth 26

September 11, 2018

InBios announces FDA clearance of its Dengue NS1 ELISA kit

October 28, 2018

ASTMH, October 28 – November 1, 2018, Sheraton new Orleans, New Orleans, LA Booth 424-426

June 2, 2018

APHL June 2 – 5, 2018, Pasadena Convention Center, Pasadena, CA

July 31, 2018

AACC July 31 – August 2, 2018, McCormick Place, Chicago, IL, Booth 540

November 13, 2017

Medica November 13 – November 16, 2017 –  Düsseldorf, Germany, Hall 3, Booth 3D29-13

July 30, 2017

AACC July 30 – August 3, 2017 – San Diego Convention Center

June 11, 2017

APHL June 11 – 14, 2017 Rhode Island Convention Center

December 19, 2016

InBios announces FDA emergency use authorization for its Zika ELISA

May 15, 2016

As Zika Virus Spreads, Gaps In Diagnostic Testing Present Opportunities For Drug Companies

May 10, 2016

UTMB researchers help discover simple, affordable diagnostic kit for chikungunya

May 5, 2016

Leishmania Rapid Diagnostic Device Receives FDA Clearance

November 11, 2014

FDA Clearance: CL Detect™ Rapid Test
Read US Army Medical Research and Material Command Press Release…

October 30, 2013

USDA Licenses InBios’ West Nile ELISA for Equine
Read the press release

August 27, 2013

New Dengue IgM ELISA Study
Read the article

September 25, 2012

InBios Keeps Pace With West Nile Outbreak
Read the article…

April 8, 2011

FDA Clearance: Dengue IgM ELISA
Read the FDA press release…

August 18, 2010

ISO Certified
InBios is ISO 13485:2003 certified.

November 19, 2004

FDA Clearance: InBios’ West Nile IgM ELISA
InBios has received 510(k) clearance from the Food and Drug Administration for its West Nile Detect IgM Capture ELISA. This in vitro diagnostic assay is highly sensitive and specific for the West Nile Virus. This kit is available worldwide.

May 26, 2003

FDA Clearance: Kalazar Detect Rapid Test
InBios has received 510(k) clearance from the Food and Drug Administration for its Kalazar Detect Rapid Test. This kit is available worldwide.